ORAMED PHARMACEUTICALS INC. (ORMP) Net income 2016–2025
ORAMED PHARMACEUTICALS INC. (ORMP) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$64.0MFY2025 · since FY2016: -$11.0M → $64.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $64.0M | +436.0% |
| FY2024 | -$19.1M | -474.6% |
| FY2023 | $5.1M | +113.9% |
| FY2022 | -$36.6M | -59.0% |
| FY2021 | -$23.0M | -99.7% |
| FY2020 | -$11.5M | +19.8% |
| FY2019 | -$14.4M | -12.8% |
| FY2018 | -$12.7M | -21.4% |
| FY2017 | -$10.5M | +4.4% |
| FY2016 | -$11.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice